Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question first ministerially corrected
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false answer text question first answered
creator	label
publisher	pref label
tabling member	label

Search

100630

	human indexable
	published
	registered interest
	answer date	06/11/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 19:36:17
	ddp modified	06/02/2015 19:17:41
	answering body	Department for Transport
	question status	Tabled
	answering dept id	27
	answering dept short name	Transport
	answering dept sort name	Transport
	hansard heading	Railways: North West
	house id	2
	identifier	HL2361
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	30/10/2014 12:12:57
	question first ministerially corrected	05/11/2014 12:17:05
	question text	To ask Her Majesty’s Government what assessment they have made of the case for improving inter-regional rail links in the North West of England, particularly between East Lancashire and Greater Manchester.
	session	2014/15
	session number	4
	tabling member printed	Baroness Massey of Darwen
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2361
	type	WrittenParliamentaryQuestion
	uin	HL2361
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The case for improving inter-regional rail links in the North West of England has been assessed in a number of studies including the Northern Hub and Network Rail’s Lancashire and Cumbria and North-West Route Utilisation strategies. The case will be further addressed in respect of Network Rail’s Control Period 6 (2019-20<ins class="ministerial">2</ins><del class="ministerial">1</del>4) and beyond through the Northern Route Study as part of Network Rail’s Long Term Planning Process to inform decisions on the Government’s Rail Investment Strategy for Control Period 6.</p> question first answered 30/10/2014 12:12:57
	creator	2489 label Biography information for Baroness Massey of Darwen
	publisher	25277 pref label House of Lords
	tabling member	2489 label Biography information for Baroness Massey of Darwen

100721

	human indexable
	published
	registered interest
	answer date	27/10/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 20:01:22
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	08/02/2015 03:52:48 23/08/2016 11:38:49
	hansard heading	Osteoporosis
	house id	1
	identifier	211732
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	29/10/2014 17:12:28
	question first ministerially corrected	13/11/2014 10:22:56
	question text	To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years.
	session	2014/15
	session number	4
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	title	House of Commons Tabled Parliamentary Question 2014/15 211732
	type	WrittenParliamentaryQuestion
	uin	211732
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> question first answered 29/10/2014 17:12:28
	creator	4026 label Biography information for Liz Kendall
	publisher	25259 pref label House of Commons
	tabling member	4026 label Biography information for Liz Kendall

100723

	human indexable
	published
	registered interest
	answer date	27/10/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 20:01:22
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	08/02/2015 03:52:58 23/08/2016 12:25:00
	hansard heading	Motor Neurone Disease: Drugs
	house id	1
	identifier	211734
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	29/10/2014 17:12:28
	question first ministerially corrected	13/11/2014 10:22:56
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years.
	session	2014/15
	session number	4
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	title	House of Commons Tabled Parliamentary Question 2014/15 211734
	type	WrittenParliamentaryQuestion
	uin	211734
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> question first answered 29/10/2014 17:12:28
	creator	4026 label Biography information for Liz Kendall
	publisher	25259 pref label House of Commons
	tabling member	4026 label Biography information for Liz Kendall

100728

	human indexable
	published
	registered interest
	answer date	27/10/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 20:01:24
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	08/02/2015 03:53:30 23/08/2016 12:25:03
	hansard heading	Motor Neurone Disease
	house id	1
	identifier	211730
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	29/10/2014 17:12:28
	question first ministerially corrected	13/11/2014 10:22:56
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years.
	session	2014/15
	session number	4
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	title	House of Commons Tabled Parliamentary Question 2014/15 211730
	type	WrittenParliamentaryQuestion
	uin	211730
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> question first answered 29/10/2014 17:12:28
	creator	4026 label Biography information for Liz Kendall
	publisher	25259 pref label House of Commons
	tabling member	4026 label Biography information for Liz Kendall

100730

	human indexable
	published
	registered interest
	answer date	27/10/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 20:01:24
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	08/02/2015 03:53:44 23/08/2016 12:25:01
	hansard heading	Osteoporosis: Drugs
	house id	1
	identifier	211735
	legislature	25259 pref label House of Commons
	parliament number	55
	question first answered	29/10/2014 17:12:28
	question first ministerially corrected	13/11/2014 10:22:56
	question text	To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to treat symptoms of osteoporosis in each of the last five years.
	session	2014/15
	session number	4
	tabling member constituency	Leicester West
	tabling member printed	Liz Kendall
	title	House of Commons Tabled Parliamentary Question 2014/15 211735
	type	WrittenParliamentaryQuestion
	uin	211735
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p> question first answered 29/10/2014 17:12:28
	creator	4026 label Biography information for Liz Kendall
	publisher	25259 pref label House of Commons
	tabling member	4026 label Biography information for Liz Kendall

100604

	human indexable
	published
	registered interest
	answer date	06/11/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 19:36:09
	ddp modified	06/02/2015 19:16:54
	answering body	Department for Business, Innovation and Skills
	question status	Tabled
	answering dept id	26
	answering dept short name	Business, Innovation and Skills
	answering dept sort name	Business, Innovation and Skills
	hansard heading	Apprentices
	house id	2
	identifier	HL2335
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	29/10/2014 17:05:23
	question text	To ask Her Majesty’s Government how many (1) 16 year-olds, (2) 17 year-olds, and (3) 18 year-olds started apprenticeships in the academic years 2012–13 and 2013–14 in England.
	session	2014/15
	session number	4
	tabling member printed	Lord Smith of Clifton
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2335
	type	WrittenParliamentaryQuestion
	uin	HL2335
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>Table 1 shows the number of apprenticeship starts for 16, 17 and 18 year olds in 2012/13 and provisional full year apprenticeship starts for the same ages in 2013/14. Provisional data are subject to change and should not be directly compared with data from earlier academic years.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p><strong>Table 1: Apprenticeship starts by age (2012/13 and 2013/14 provisional full year)</strong></p><p> </p><table><tbody><tr><td><p><strong> </strong></p></td><td><p><strong>2012/13</strong></p></td><td><p><strong>2013/14</strong></p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p>Full year</p></td></tr><tr><td><p>Age</p></td><td><p>Full year</p></td><td><p>(provisional)</p></td></tr><tr><td><p>16</p></td><td><p>25,080</p></td><td><p>25,170</p></td></tr><tr><td><p>17</p></td><td><p>35,810</p></td><td><p>38,320</p></td></tr><tr><td><p>18</p></td><td><p>53,430</p></td><td><p>54,140</p></td></tr></tbody></table><p> </p><p>Notes</p><p> </p><p>1) Volumes are rounded to the nearest 10.</p><p> </p><p>2) Age is calculated based on age at start of the programme rather than based on 31 August.</p><p> </p><p>3) Provisional data are subject to change and should not be directly compared with data from earlier academic years.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p><p> </p> question first answered 29/10/2014 17:05:23
	creator	3144 label Biography information for Lord Smith of Clifton
	publisher	25277 pref label House of Lords
	tabling member	3144 label Biography information for Lord Smith of Clifton

100605

	human indexable
	published
	registered interest
	answer date	06/11/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 19:36:09
	ddp modified	06/02/2015 19:16:55
	answering body	Foreign and Commonwealth Office
	question status	Tabled
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Council of Europe
	house id	2
	identifier	HL2336
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	03/11/2014 15:18:50
	question text	To ask Her Majesty’s Government whether they will be represented at the forthcoming Council of Europe conference in Baku, Azerbaijan; and what representations they will make regarding the implementation of recent European Court of Human Rights decisions concerning Azerbaijan.
	session	2014/15
	session number	4
	tabling member printed	Lord Hylton
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2336
	type	WrittenParliamentaryQuestion
	uin	HL2336
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The British Government takes all opportunities to raise its concerns about the lack of fundamental freedoms in Azerbaijan, including the implementation of judgments by the European Court of Human Rights, and does so at a range of levels on a regular basis. The UK will be represented at official level at Azerbaijan's forthcoming closing Council of Europe conference in Baku.</p> question first answered 03/11/2014 15:18:50
	creator	2018 label Biography information for Lord Hylton
	publisher	25277 pref label House of Lords
	tabling member	2018 label Biography information for Lord Hylton

100608

	human indexable
	published
	registered interest
	answer date	06/11/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 19:36:10
	ddp modified	06/02/2015 19:17:00
	answering body	Foreign and Commonwealth Office
	question status	Tabled
	answering dept id	16
	answering dept short name	Foreign and Commonwealth Office
	answering dept sort name	Foreign and Commonwealth Office
	hansard heading	Civil Servants: Languages
	house id	2
	identifier	HL2339
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	03/11/2014 15:37:02
	question text	To ask Her Majesty’s Government how many diplomatic staff and civil servants from each department or government agency have received or are receiving language training at the Foreign and Commonwealth Office Language School.
	session	2014/15
	session number	4
	tabling member printed	Baroness Coussins
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2339
	type	WrittenParliamentaryQuestion
	uin	HL2339
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>Since the Language Centre opened on 19th September 2013 a total of 45 different languages have been studied there either full or part-time by 813 students. Of those students, 779 are Foreign and Commonwealth Office (FCO) staff and 34 are from other government departments (OGDs) (including staff from the following departments: Ministry of Defence, Cabinet Office, the Department for Business, Innovation &amp; Skills, Home Office, Ministry of Justice, UK Trade and Investment, the Department for International Development, HM Revenue and Customs, the Department for Environment, Food and Rural Affairs, the Department of Energy and Climate Change, and the House of Commons). An additional 60 FCO staff have trained at the Institut Francais. Staff across the Civil Service can also access the FCO Language Centre library to continue to develop their own language skills outside formal study and 58 OGD staff have taken advantage of this offer so far. <br><br>It is important to note that when more appropriate, staff from OGDs also receive language training outside of the FCO Language Centre through use of the Civil Service-wide contract with Language Services Direct (the company that run the FCO Language Centre) or at the Institut Francais if French is required. Since September 2014, 113 OGD students have received language training on their own premises via the FCO contract. <br><br>The table below provides a breakdown of the languages that have been taught at the FCO Language Centre :<br><br>Albanian 2 <br>Arabic 186 <br>Azeri 1 <br>Bosnian 1 <br>Bulgarian 3 <br>Burmese 1 <br>Cambodian 1 <br>Czech 1 <br>Danish 2 <br>Dari 5 <br>Dutch 5 <br>Farsi 33 <br>Finnish 1 <br>French 14 <br>Georgian 1 <br>German 40 <br>Greek 4 <br>Hebrew 1 <br>Hindi 20 <br>Indonesian 4 <br>Italian 23 <br>Japanese 33 <br>Korean 8 <br>Macedonian 1 <br>Mandarin 93 <br>Norwegian 1 <br>Pashto 5 <br>Polish 3 <br>Portuguese 47 <br>Romanian 3 <br>Russian 84 <br>Serbian 3 <br>Sinhalese 1 <br>Slovak 1 <br>Slovene 1 <br>Spanish 153 <br>Swedish 3 <br>Tajik 1 <br>Thai 2 <br>Tigrinya 1 <br>Turkish 11 <br>Turkmen 1 <br>Urdu 4 <br>Uzbek 2 <br>Vietnamese 2 <br>Total 813</p> question first answered 03/11/2014 15:37:02
	creator	3829 label Biography information for Baroness Coussins
	publisher	25277 pref label House of Lords
	tabling member	3829 label Biography information for Baroness Coussins

100617

	human indexable
	published
	registered interest
	answer date	06/11/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 19:36:13
	ddp modified	06/02/2015 19:17:24
	answering body	Department for Education
	question status	Tabled
	answering dept id	60
	answering dept short name	Education
	answering dept sort name	Education
	hansard heading	Sports: Primary Education
	house id	2
	identifier	HL2348
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	03/11/2014 17:15:50
	question text	To ask Her Majesty’s Government, following the commitments made after the Olympic Games, what plans they have to increase the time allocated and resources spent per pupil on sport in all primary schools; and what additional resources will be allocated for that purpose.
	session	2014/15
	session number	4
	tabling member printed	Lord Hunt of Chesterton
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2348
	type	WrittenParliamentaryQuestion
	uin	HL2348
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>All maintained schools must teach a full programme of study for PE and it is up to schools to decide how much time they should devote to PE, or indeed to any other national curriculum subject. New research has shown that primary school pupils are now spending an average of more than two hours a week in PE lessons – an increase of 13 minutes since last year. Through the primary PE and sport premium we are providing over £450 million of ring-fenced funding across the three academic years beginning in 2013/14. The premium goes directly to primary schools to be spent on PE and sport; our research has shown that over 90% of schools have improved the quality of their PE lessons as a direct result of this funding.</p> question first answered 03/11/2014 17:15:50
	creator	2543 label Biography information for Lord Hunt of Chesterton
	publisher	25277 pref label House of Lords
	tabling member	2543 label Biography information for Lord Hunt of Chesterton

100620

	human indexable
	published
	registered interest
	answer date	06/11/2014
	date	23/10/2014
	date tabled	23/10/2014
	ddp created	23/10/2014 19:36:14
	ddp modified	06/02/2015 19:17:28
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS
	house id	2
	identifier	HL2351
	legislature	25277 pref label House of Lords
	parliament number	55
	question first answered	31/10/2014 13:18:46
	question text	To ask Her Majesty’s Government how the Secretary of State for Health has discharged his duty to report on the treatment of National Health Service health care providers as specified in section 8 of the Health and Social Care Act 2012.
	session	2014/15
	session number	4
	tabling member printed	Lord Hunt of Kings Heath
	title	House of Lords Tabled Parliamentary Question 2014/15 HL2351
	type	WrittenParliamentaryQuestion
	uin	HL2351
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answer text <p>The Secretary of State commissioned Monitor to lead a Fair Playing Field Review into the equal treatment of providers of National Health Service services. The Review published its final Report in March 2013. Since publication, Monitor has established a high level implementation group, of which the Department is a member, to take forward the Review’s recommendations.</p><p> </p><p><strong> </strong></p><p> </p><p>As part of its annual assurance processes the Department seeks confirmation from all its Directors General that they and our Arm’s Length Bodies have taken the duty into consideration, as outlined in Section 8 of the Health and Social Care Act 2012.</p><p> </p> question first answered 31/10/2014 13:18:46
	creator	2024 label Biography information for Lord Hunt of Kings Heath
	publisher	25277 pref label House of Lords
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath